NEW YORK -- (Business Wire)
Kirby McInerney LLP is investigating potential claims against FedEx
Corporation (“FedEx” or the “Company”) (NYSE:FDX) concerning whether the
Company and its executives violated their fiduciary duties.
On July 17, 2014, FedEx stated in a regulatory filing that it has
“received requests for information from the U.S. Department of Justice
(“DOJ”) in the Northern District of California in connection with a
criminal investigation relating to the transportation of packages for
online pharmacies that may have shipped pharmaceuticals in violation of
federal law. On July 17, 2014, the DOJ filed a criminal indictment in
the United States District Court for the Northern District of California
in connection with the matter.” The indictment alleges that FedEx
Corporation, FedEx Express and FedEx Services, together with certain
pharmacies, conspired to unlawfully distribute controlled substances and
misbranded drugs. According to a press release issued by the DOJ in
connection with the indictment, as early as 2004, “FedEx knew that it
was delivering drugs to dealers and addicts” as FedEx’s couriers
“expressed safety concerns that were circulated to FedEx Senior
management, including that FedEx trucks were stopped on the road by
online pharmacy customers demanding package of pills.”
If you are a FedEx stockholder and have information that could assist in
this investigation, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com,
or telephone at (212) 699-1145, or Melissa Fortunato, Esq. by email at mfortunato@kmllp.com,
or telephone at (212) 699-1141, or toll free at (888) 529-4787, or by filling
out this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating in
securities, stockholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to www.kmllp.com.
Contacts:
Kirby McInerney LLP
J. Brandon Walker, Esq, 212-699-1145
bwalker@kmllp.com
or
Melissa
Fortunato, Esq., 212-699-1141
toll free: 888-529-478
mfortunato@kmllp.com
Source: Kirby McInerney LLP
© 2024 Canjex Publishing Ltd. All rights reserved.